Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

A Machine Learning-Based Workflow for Predicting Transplant Outcome in Patients with Sickle Cell Disease

Haiou Li, Vandana Sachdev, Xin Tian, My-Le Nguyen, Matthew Hsieh, Courtney D. Fitzhugh, Emily Limerick, Wynona Coles, Nancy Asomaning, Anna Conrey, Colin O. Wu, Swee Lay Thein

Blood (2024) 144 (Supplement 1): 177.

https://doi.org/10.1182/blood-2024-194897

Published: 2024

Journal Articles

Fertility Preservation Outcomes for People with Ovaries and Sickle Cell Anemia: A Multi-Center Study

Marti Goldenberg, Sarah C. Cromack, Jessica Walter, Jayla Lynn Scott, Howard J. Li, Julia Varga, Alan Decherney, Courtney D. Fitzhugh, Emily Limerick, Matthew Hsieh, Margaret Rush, Clarisa Gracia, Lisa Shandley, Kerri Andre, Jennifer Fay Kawwass, Kamaria C. Cayton Vaught, Katherine Cameron, Lydia H. Pecker

Blood (2024) 144 (Supplement 1): 802.

https://doi.org/10.1182/blood-2024-194008

Published: 2024

Journal Articles

Assessing Real-Time Sickling Kinetics in Individual Cells from Erythrocyte Populations of Subjects with Different HbA, HbS and HbF Percentages

Aliya U. Zaidi, Xiufeng Gao, Robert Goodrich, Marta Ferranti, Rasa Borhan, Ke Liu, Nnamdi Okeke, Michael Tarasev, Mariama Kabore, Courtney D. Fitzhugh, Priya Sethu Chockalingam, Patrick C. Hines

Blood (2023) 142 (Supplement 1): 1118.

https://doi.org/10.1182/blood-2023-190404

Published: 2023

Journal Articles

SCD Dyslipidemia Normalizes Long-Term Following Nonmyeloablative Hematopoietic Cell Transplantation

Jackie Queen, Emily Limerick, Neal Jeffries, Ritika Menon, Matthew M. Hsieh, Robert Shamburek, Courtney D. Fitzhugh

Blood (2023) 142 (Supplement 1): 929.

https://doi.org/10.1182/blood-2023-186341

Published: 2023

Journal Articles

Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism

Rialnat A. Lawal, Devdeep Mukherjee, Emily M. Limerick, Wynona Coles, Matthew M. Hsieh, Laura W. Dillon, Christopher S. Hourigan, Courtney D. Fitzhugh

Blood (2022) 140 (23): 2514–2518.

https://doi.org/10.1182/blood.2022017960

Published: 2022

Journal Articles

Pulmonary Function before and after Hematopoietic Cell Transplant in People Living with Sickle Cell Disease

Amy Parker Ruhl, Ruba Shalhoub, Neal Jeffries, Alexis Leonard, Emily Limerick, Amisha Barochia, Matthew M. Hsieh, Courtney D. Fitzhugh

Blood (2022) 140 (Supplement 1): 8294–8295.

https://doi.org/10.1182/blood-2022-157235

Published: 2022

Journal Articles

Percent Patient NK and T Cells at Day 28 Predict Graft Outcome after Haploidentical Hematopoietic Cell Transplant for Sickle Cell Disease

Mariah Jensen-Wachspress, Haili Lang, Gelina Sani, Deepali K Bhat, Emily Limerick, Xin Xu, Kenneth Fulton, Catherine M Bollard, Courtney D. Fitzhugh, Allistair Abraham

Blood (2022) 140 (Supplement 1): 7609–7610.

https://doi.org/10.1182/blood-2022-166878

Published: 2022

Journal Articles

Pentostatin Plus Cyclophosphamide Decrease Graft Rejection in Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease

Emily Limerick, Mary Lacy Grecco, Julia Varga, Jennifer Brooks, Wynona Coles, R. AdeBisi Lawal, Neal Jeffries, Matthew M. Hsieh, Courtney D. Fitzhugh

Blood (2022) 140 (Supplement 1): 7572–7573.

https://doi.org/10.1182/blood-2022-169796

Published: 2022

Journal Articles

Optimization of Autologous Hematopoietic Progenitor Stem Cell Apheresis Collection from Plerixafor-Mobilized Patients with Sickle Cell Disease

Blood (2021) 138 (Supplement 1): 1770.

https://doi.org/10.1182/blood-2021-146669

Published: 2021

Journal Articles

Nonmyeloablative Transplant for Sickle Cell Disease Does Not Lead to Kidney Dysfunction Post-HSCT

Emily Limerick, Santosh L. Saraf, Neal Jeffries, Farah O'Boyle, Clarissa Diamantidis, Yuliya Lokhnygina, Matthew M. Hsieh, Josu de la Fuente, Courtney D. Fitzhugh

Blood (2021) 138 (Supplement 1): 984.

https://doi.org/10.1182/blood-2021-153230

Published: 2021

Journal Articles

Long-Term Cardiac Effects of Successful Non-Myeloablative HLA-Matched Sibling Transplants in Sickle Cell Disease

Vandana Sachdev, My-Le Nguyen, Wen Li, Neal Jeffries, Shalini S Ramachandra, David Tofovic, Damiano Rondelli, Matthew Hsieh, Santosh L. Saraf, Courtney D. Fitzhugh

Blood (2021) 138 (Supplement 1): 2898.

https://doi.org/10.1182/blood-2021-148173

Published: 2021

Journal Articles

Renal Function Is Preserved after Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Emily Limerick, MD, Neal Jeffries, PhD, Clarissa Diamantidis, MD, Yuliya Lokhnygina, PhD, Matthew M. Hsieh, MD, Courtney D. Fitzhugh, MD

Blood (2020) 136 (Supplement 1): 58–59.

https://doi.org/10.1182/blood-2020-142630

Published: 2020

Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Adetola A. Kassim, MDMS, Josu de la Fuente, Ali Debsan Alahmari, MBBS, MD MNAMS, Michael J. Eckrich, MD MPH, Rabi Hanna, MD, Nathalie Dhedin, MD, Biljana N. Horn, MD, Vandy Black, MDMSc, Roseane V Gouveia, Adriana Seber, MDMS, Belinda Pinto Simões, MD PhD, Thalita Cristina de Mello Costa, MD, Renato Guerino-Cunha, Carmem M. S. Bonfim, MDPhD, Roberto Luiz da Silva, Nelson Hamerschlak, MD PhD, Juliana Folloni Fernandes, MD, Michael Kent, MDBS, Satya Prakash Yadav, MBBS, MD, Erfan Nur, MDPhD, Mohsen Alzahrani, Ben Carpenter, PhD, William Tse, MD, Maria Isabel, Hemalatha G Rangarajan, MD, Ibrahim Ahmed, MD, Adeseye Michael Akinsete, MBBS, Courtney D. Fitzhugh, MD, Kathryn A. Culos, PharmD, Leena Karnik, FRCPath, MRCP, James Connelly, MD, Carrie Kitko, MD, Jennifer Andrews, MDMSc, Karina L Wilkerson, NP, MSN, Robert Brodsky, Tatsuki Koyama, Michael R. DeBaun, MD MPH

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-141771

Published: 2020

Journal Articles

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Ruta Brazauskas, Graziana M. Scigliuolo, Hai-Lin Wang, Barbara Cappelli, Annalisa Ruggeri, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J. Meerpohl, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, Mark C. Walters, John E. Wagner, John F. Tisdale, Eliane Gluckman, Mary Eapen

Blood (2020) 136 (5): 623–626.

https://doi.org/10.1182/blood.2020005687

Published: 2020

Includes: Supplemental data

Journal Articles

Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

Jack Y. Ghannam, Xin Xu, Irina Maric, Laura Dillon, Yuesheng Li, Matthew M. Hsieh, Christopher S. Hourigan, Courtney D. Fitzhugh

Blood (2020) 135 (14): 1185–1188.

https://doi.org/10.1182/blood.2019004001

Published: 2020

Journal Articles

Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study

Omar Niss, MD, Adam Lane, PhD, Monika Asnani, PhD, Marianne McPherson Yee, MD MSc, Ashok Raj, Susan E Creary, MD, Courtney D. Fitzhugh, MD, Prasad V. Bodas, MD, Santosh L. Saraf, MD, Sharada Sarnaik, MD, Charles T. Quinn, MD, Prasad Devarajan, MD, Punam Malik, MD

Blood (2019) 134 (Supplement_1): 1004.

https://doi.org/10.1182/blood-2019-125860

Published: 2019

Journal Articles

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

Alexis Leonard, MD, Naoya Uchida, MD, David F. Stroncek, MD, Sandhya R. Panch, MDMPH, Kamille West, Eoghan George Molloy, MD, Tom Hughes, Pharm.D., Sara Hauffe, RN, Tiffani Taylor, Courtney D. Fitzhugh, MD, Jane S. Hankins, MD MS, Megan Wilson, MSW, CCRP, Akshay Sharma, MBBS, Shengdar Q. Tsai, PhD, Mitchell J. Weiss, MD, PhD, Matthew Hsieh, MD, John F. Tisdale, MD

Blood (2019) 134 (Supplement_1): 1964.

https://doi.org/10.1182/blood-2019-126091

Published: 2019

Journal Articles

Characterization of Immune Cells Producing Regulatory Cytokines That Mediate Engraftment in Sickle Cell Disease Patients after Haploidentical Peripheral Blood Stem Cell Transplantation

Berline Francis, Arunakumar Gangaplara, PhD, Deepali K Bhat, PhD, J. Philip McCoy, PhD, Courtney D. Fitzhugh, MD

Blood (2019) 134 (Supplement_1): 803.

https://doi.org/10.1182/blood-2019-130711

Published: 2019

Journal Articles

Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT

Ahmad Shaikh, Purevdorj Olkhanud, MD PhD, Marjan Gucek, PhD, Sajni Patel, MS, Courtney D. Fitzhugh, MD

Blood (2018) 132 (Supplement 1): 201.

https://doi.org/10.1182/blood-2018-99-118654

Published: 2018

Journal Articles

Pain and Opioid Use after Reversal of Sickle Cell Disease Following Hematopoietic Stem Cell Transplant

Deepika S. Darbari, MD, Jaquette Liljencrantz, MD, Austin Ikechi, Staci Martin, PhD, Roderick Marie Claire, Courtney D. Fitzhugh, MD, John F Tisdale, MD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Matthew Hsieh, MD

Blood (2017) 130 (Supplement 1): 970.

https://doi.org/10.1182/blood.V130.Suppl_1.970.970

Published: 2017

NARROW

A Machine Learning-Based Workflow for Predicting Transplant Outcome in Patients with Sickle Cell Disease

Fertility Preservation Outcomes for People with Ovaries and Sickle Cell Anemia: A Multi-Center Study

Assessing Real-Time Sickling Kinetics in Individual Cells from Erythrocyte Populations of Subjects with Different HbA, HbS and HbF Percentages

SCD Dyslipidemia Normalizes Long-Term Following Nonmyeloablative Hematopoietic Cell Transplantation

Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism

Pulmonary Function before and after Hematopoietic Cell Transplant in People Living with Sickle Cell Disease

Percent Patient NK and T Cells at Day 28 Predict Graft Outcome after Haploidentical Hematopoietic Cell Transplant for Sickle Cell Disease

Pentostatin Plus Cyclophosphamide Decrease Graft Rejection in Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease

Optimization of Autologous Hematopoietic Progenitor Stem Cell Apheresis Collection from Plerixafor-Mobilized Patients with Sickle Cell Disease

Nonmyeloablative Transplant for Sickle Cell Disease Does Not Lead to Kidney Dysfunction Post-HSCT

Long-Term Cardiac Effects of Successful Non-Myeloablative HLA-Matched Sibling Transplants in Sickle Cell Disease

Renal Function Is Preserved after Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

Characterization of Immune Cells Producing Regulatory Cytokines That Mediate Engraftment in Sickle Cell Disease Patients after Haploidentical Peripheral Blood Stem Cell Transplantation

Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT

Pain and Opioid Use after Reversal of Sickle Cell Disease Following Hematopoietic Stem Cell Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only